...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Gasoline

Those of us who owned RVX were, "gifted" one share of Zenith for every share held of RVX around the time of the split.

Share
New Message
Please login to post a reply